Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary Holmes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|August 10, 2022
Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapyZachary Holmes, Ashling Courtney, Alison Hiong
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 18, 2024
Determining QTc in acute care settings: What we (don't) knowZachary Holmes, Dustin Orvin, John Carr
BMJ Case Reports|January 3, 2024
Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisationZachary Holmes, Hermione Beasley, Mahendra Naidoo, et al.
The Australasian Journal of Dermatology|March 24, 2023
Intravenous immunoglobulin treatment for refractory pyoderma gangrenosumJacqueline K Nguyen, Zachary Holmes, Robert I Kelly
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
BMJ Case Reports|June 17, 2021
Unusual presentation of infective endocarditis in ICUMarc Lincoln, Zachary Holmes, Alexander Robinson, et al.
The Australasian Journal of Dermatology|May 30, 2024
Tildrakizumab use for recalcitrant pityriasis rubra pilarisZachary Holmes, Michelle S Goh, Peter Foley, et al.
The Australasian Journal of Dermatology|April 27, 2023
Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulinZachary Holmes, Jacqueline Nguyen, Ashling Courtney, et al.
The Australasian Journal of Dermatology|February 8, 2025
Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant DiseaseZachary Holmes, Conor Larney, Peter Foley, et al.
Optics Letters|September 1, 2023
Multiple beam coherent combination via an optical ring resonatorNina Bode, Zachary Holmes, Sebastian Ng, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|August 10, 2022
Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapyZachary Holmes, Ashling Courtney, Alison Hiong
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 18, 2024
Determining QTc in acute care settings: What we (don't) knowZachary Holmes, Dustin Orvin, John Carr
BMJ Case Reports|January 3, 2024
Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisationZachary Holmes, Hermione Beasley, Mahendra Naidoo, et al.
The Australasian Journal of Dermatology|March 24, 2023
Intravenous immunoglobulin treatment for refractory pyoderma gangrenosumJacqueline K Nguyen, Zachary Holmes, Robert I Kelly
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
BMJ Case Reports|June 17, 2021
Unusual presentation of infective endocarditis in ICUMarc Lincoln, Zachary Holmes, Alexander Robinson, et al.
The Australasian Journal of Dermatology|May 30, 2024
Tildrakizumab use for recalcitrant pityriasis rubra pilarisZachary Holmes, Michelle S Goh, Peter Foley, et al.
The Australasian Journal of Dermatology|April 27, 2023
Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulinZachary Holmes, Jacqueline Nguyen, Ashling Courtney, et al.
The Australasian Journal of Dermatology|February 8, 2025
Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant DiseaseZachary Holmes, Conor Larney, Peter Foley, et al.
Optics Letters|September 1, 2023
Multiple beam coherent combination via an optical ring resonatorNina Bode, Zachary Holmes, Sebastian Ng, et al.
Pageof 2